These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6141899)
1. Commentary: pharmacologic prospects of the therapeutic use of administered enzymes. Sato PH Drug Metab Dispos; 1984; 12(1):1-3. PubMed ID: 6141899 [No Abstract] [Full Text] [Related]
8. Enzyme therapy in lysosomal storage diseases: current approaches. Rattazzi MC Prog Clin Biol Res; 1982; 103 Pt B():573-87. PubMed ID: 6219401 [No Abstract] [Full Text] [Related]
9. Immobilized enzymes. Their applications in medicine. Anderson PM; Salo WL Minn Med; 1973 Dec; 56(12):1036-40. PubMed ID: 4800830 [No Abstract] [Full Text] [Related]
10. Animal model studies: enzyme entrapment, neural delivery, and transplantation--summary and discussion. Chang TM Birth Defects Orig Artic Ser; 1980; 16(1):231-5. PubMed ID: 7448356 [No Abstract] [Full Text] [Related]
12. Enzyme manipulation: mechanisms and therapeutic trials--summary and discussion. Hommes FA Birth Defects Orig Artic Ser; 1980; 16(1):335-40. PubMed ID: 7448360 [No Abstract] [Full Text] [Related]
13. Microbial enzymes in clinical investigation, diagnosis and therapy. Smith CE J Gen Microbiol; 1971 Mar; 65(3):x. PubMed ID: 5556685 [No Abstract] [Full Text] [Related]
14. An appraisal of human trials in enzyme replacement therapy of genetic diseases. Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527 [No Abstract] [Full Text] [Related]
15. [Future possibilities for the treatment of hereditary metabolic diseases]. Watts RW Monatsschr Kinderheilkd; 1983 Jun; 131(6):305-10. PubMed ID: 6350850 [No Abstract] [Full Text] [Related]
16. Letter: Enzyme-carrier potential of liposomes in enzyme replacement therapy. Gregoriadis G N Engl J Med; 1975 Jan; 292(4):215. PubMed ID: 1109221 [No Abstract] [Full Text] [Related]
17. Immobilization in hypoallergenic gel, a method of protecting enzymes from proteolysis and antibody complexing. Updike S; Prieve C; Magnuson J Birth Defects Orig Artic Ser; 1973 Mar; 9(2):77-80. PubMed ID: 4611540 [No Abstract] [Full Text] [Related]
18. Enzyme manipulation by specific megavitamin therapy. Fleisher LD; Gaull GE Birth Defects Orig Artic Ser; 1980; 16(1):239-67. PubMed ID: 7004517 [No Abstract] [Full Text] [Related]
19. Human trials: cell and organ transplantation/other therapeutic approaches--summary and discussion. Barker CF Birth Defects Orig Artic Ser; 1980; 16(1):509-15. PubMed ID: 7448361 [No Abstract] [Full Text] [Related]
20. New trends in the treatment of inborn errors of metabolism: an overview. Frézal J; Munnich A; Ogier H; Weil D; Saudubray JM Prog Clin Biol Res; 1982; 103 Pt B():563-71. PubMed ID: 7163247 [No Abstract] [Full Text] [Related] [Next] [New Search]